Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Preferred Stock Liabilities: 2016-2025

Historic Preferred Stock Liabilities for Organogenesis Holdings (ORGO) over the last 3 years, with Sep 2025 value amounting to $130.9 million.

  • Organogenesis Holdings' Preferred Stock Liabilities was N/A to $130.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.9 million, marking a year-over-year change of. This contributed to the annual value of $122.4 million for FY2024, which is N/A change from last year.
  • Per Organogenesis Holdings' latest filing, its Preferred Stock Liabilities stood at $130.9 million for Q3 2025, which was up 2.25% from $128.0 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Preferred Stock Liabilities registered a high of $130.9 million during Q3 2025, and its lowest value of $122.4 million during Q4 2024.
  • Moreover, its 2-year median value for Preferred Stock Liabilities was $126.6 million (2025), whereas its average is $126.6 million.